newsfilter
← Latest News
PR Newswire·

Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders

Avidity Biosciences, Inc. ("Avidity") (NASDAQ: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called...